Expression of Na,K-ATPase-β1 subunit increases uptake and sensitizes carcinoma cells to oxaliplatin

Cancer Chemotherapy and Pharmacology

Volumn 64, Issue 6, 2009, Pages 1187-1194

  Tummala, Ramakumar ^a   Wolle, Daniel ^b   Barwe, Sonali P ^b   Sampson, Valerie B ^b   Rajasekaran, Ayyappan K ^b   Pendyala, Lakshmi ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CELL ADHESION MOLECULE; FIBRONECTIN; OUABAIN; OXALIPLATIN; SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE ALPHA1; SODIUM POTASSIUM ADENOSINE TRIPHOSPHATASE BETA1; SULFORHODAMINE B; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; CANCER CELL CULTURE; CANCER RESISTANCE; CARCINOMA CELL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG CYTOTOXICITY; DRUG SENSITIVITY; DRUG SENSITIZATION; DRUG TUMOR LEVEL; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME SUBUNIT; EPITHELIUM CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MESENCHYME CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; CADHERINS; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DOGS; DRUG RESISTANCE, NEOPLASM; FEMALE; FIBRONECTINS; GENE EXPRESSION; HUMANS; KIDNEY NEOPLASMS; ORGANOPLATINUM COMPOUNDS; OUABAIN; OVARIAN NEOPLASMS; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRANSFECTION;

EID: 69049093771     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-0985-x     Document Type: Article

References (37)

1. Z Ahmed Y Deyama Y Yoshimura K Suzuki 2008 Cisplatin sensitivity of oral squamous carcinoma cells is regulated by Na(+), K(+)-ATPase activity rather than copper-transporting P-type ATPases, ATP7A and ATP7B Cancer Chemother Pharmacol 63 4 643 650
2. PA Andrews 1994 Mechanisms of acquired resistance to cisplatin Cancer Treat Res 73 217 248
3. PA Andrews SC Mann HH Huynh KD Albright 1991 Role of the Na+,K(+)-adenosine triphosphatase in the accumulation of cis- diamminedichloroplatinum(II) in human ovarian carcinoma cells Cancer Res 51 3677 3681
4. PA Andrews S Velury SC Mann SB Howell 1988 cis- Diamminedichloroplatinum(II) accumulation in sensitive and resistant human ovarian carcinoma cells Cancer Res 48 68 73
5. T Bando M Fujimura K Kasahara T Matsuda 1998 Significance of Na+,K(+)-ATPase on intracellular accumulation of cis- diamminedichloroplatinum(II) in human non-small-cell but not in small-cell lung cancer cell lines Anticancer Res 18 1085 1089
6. SP Barwe G Anilkumar SY Moon Y Zheng JP Whitelegge SA Rajasekaran AK Rajasekaran 2005 Novel role for Na,K-ATPase in phosphatidylinositol 3-kinase signaling and suppression of cell motility Mol Biol Cell 16 1082 1094
7. SP Barwe S Kim SA Rajasekaran JU Bowie AK Rajasekaran 2007 Janus model of the Na,K-ATPase beta-subunit transmembrane domain: distinct faces mediate alpha/beta assembly and beta-beta homo-oligomerization J Mol Biol 365 706 714
8. P Borst M Kool R Evers 1997 Do cMOAT (MRP2), other MRP homologues and LRP play a role in MDR? Semin Cancer Biol 8 205 213
9. Z El-akawi M Abu-hadid R Perez J Glavy J Zdanowicz PJ Creaven L Pendyala 1996 Altered glutathione metabolism in oxaliplatin resistant A2780 ovarian carcinoma cells Cancer Let 105 5 14
10. T Elliott T Sethi 2002 Integrins and extracellular matrix Expert Rev Anticancer Ther 2 449 459
11. CE Espineda JH Chang J Twiss SA Rajasekaran AK Rajasekaran 2004 Repression of Na,K-ATPase beta1-subunit by the transcription factor snail in carcinoma Mol Biol Cell 15 1364 1373
12. M Gosland B Lum J Schimmelpfennig J Baker M Doukas 1996 Insights into mechanisms of cisplatin resistance and potential for its clinical reversal Pharmacotherapy 16 16 39
13. M Guarino B Rubino G Ballabio 2007 The role of epithelial-mesenchymal transition in cancer pathology Pathology (Phila) 39 305 318
14. MD Hall M Okabe DW Shen XJ Liang MM Gottesman 2008 The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy Annu Rev Pharmacol Toxicol 48 495 535
15. S Hector W Bolanowska-Higdon J Zdanowicz S Hitt L Pendyala 2001 In vitro studies on the mechanisms of oxaliplatin resistance Cancer Chemother Pharmacol 48 398 406
16. S Hector ME Nava K Clark M Murpy L Pendyala 2007 Characterization of a clonal isolate of an oxaliplatin resistant ovarian carcinoma cell line A2780/C10 Cancer Lett 245 195 204
17. MA Huber N Kraut H Beug 2005 Molecular requirements for epithelial-mesenchymal transition during tumor progression Curr Opin Cell Biol 17 548 558
18. LJ Inge SA Rajasekaran K Yoshimoto PS Mischel W McBride E Landaw AK Rajasekaran 2008 Evidence for a potential tumor suppressor role for the Na,K-ATPase beta1-subunit Histol Histopathol 23 459 467
19. EA Jewell JB Lingrel 1991 Comparison of the substrate dependence properties of the rat Na,K-ATPase alpha 1, alpha 2, and alpha 3 isoforms expressed in HeLa cells J Biol Chem 266 16925 16930
20. SW Johnson D Shen I Pastan MM Gottesman TC Hamilton 1996 Cross-resistance, cisplatin accumulation, and platinum-DNA adduct formation and removal in cisplatin-sensitive and -resistant human hepatoma cell lines Exp Cell Res 226 133 139
21. H Kajiyama K Shibata M Terauchi M Yamashita K Ino A Nawa F Kikkawa 2007 Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells Int J Oncol 31 277 283
22. K Katano A Kondo R Safaei A Holzer G Samimi M Mishima YM Kuo M Rochdi SB Howell 2002 Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper Cancer Res 62 6559 6565
23. H Koga S Kotoh M Nakashima A Yokomizo M Tanaka S Naito 2000 Accumulation of intracellular platinum is correlated with intrinsic cisplatin resistance in human bladder cancer cell lines Int J Oncol 16 1003 1007
24. G Mathe Y Kidani M Segiguchi M Eriguchi G Fredj G Peytavin JL Misset S Brienza F de Vassals E Chenu C Bourut 1991 Oxalato-platinum or l-OHP, a third generation platinum complex: an experimental and clinical appraisal and preliminary comparison with cis-platinum and carboplatinum Biomed Pharmacother 43 237 250
25. CA Rabik ME Dolan 2007 Molecular mechanisms of resistance and toxicity associated with platinating agents Cancer Treat Rev 33 9 23
26. SA Rajasekaran KW Beyenbach AK Rajasekaran 2008 Interactions of tight junctions with membrane channels and transporters Biochim Biophys Acta 1778 757 769
27. SA Rajasekaran J Gopal D Willis C Espineda JL Twiss AK Rajasekaran 2004 Na,K-ATPase beta1-subunit increases the translation efficiency of the alpha1-subunit in MSV-MDCK cells Mol Biol Cell 15 3224 3232
28. SA Rajasekaran LG Palmer K Quan JF Harper WJ Ball Jr NH Bander SA Peralta AK Rajasekaran 2001 Na,K-ATPase beta-subunit is required for epithelial polarization, suppression of invasion, and cell motility Mol Biol Cell 12 279 295
29. R Safaei 2006 Role of copper transporters in the uptake and efflux of platinum containing drugs Cancer Lett 234 34 39
30. CA Sherman-Baust AT Weeraratna LB Rangel ES Pizer KR Cho DR Schwartz T Shock PJ Morin 2003 Remodeling of the extracellular matrix through overexpression of collagen VI contributes to cisplatin resistance in ovarian cancer cells Cancer Cell 3 377 386
31. L Shoshani RG Contreras ML Roldan J Moreno A Lazaro MS Balda K Matter M Cereijido 2005 The polarized expression of Na+,K+-ATPase in epithelia depends on the association between beta-subunits located in neighboring cells Mol Biol Cell 16 1071 1081
32. J Tse R Kalluri 2007 Mechanisms of metastasis: epithelial to mesenchymal transition and contribution of tumor microenvironment J Cell Biochem 101 816 829
33. O Vagin E Tokhtaeva G Sachs 2006 The role of the beta1 subunit of the Na,K-ATPase and its glycosylation in cell-cell adhesion J Biol Chem 281 39573 39587
34. RR Varma S Hector K Clark WR Greco L Hawthorn L Pendyala 2005 Gene expression profiling of a clonal isolate of oxaliplatin resistant ovarian carcinoma cell line A2780/C10 Oncol Rep 14 925 932
35. LR Wiseman JC Adkins GL Plosker K Goa 1999 Oxaliplatin. A review of its use in the management of metastatic colorectal cancer Drugs Aging 14 459 475
36. AD Yang F Fan ER Camp BG Van W Liu R Somcio MJ Gray H Cheng PM Hoff LM Ellis 2006 Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines Clin Cancer Res 12 4147 4153
37. S Zhang KS Lovejoy JE Shima LL Lagpacan Y Shu A Lapuk Y Chen T Komori JW Gray X Chen SJ Lippard KM Giacomini 2006 Organic cation transporters are determinants of oxaliplatin cytotoxicity Cancer Res 66 8847 8857